ESCRS - Barrett True K formula provides accurate results in post-refractive surgery patient ;
ESCRS - Barrett True K formula provides accurate results in post-refractive surgery patient ;

Barrett True K formula provides accurate results in post-refractive surgery patient

Barrett True K formula provides accurate results in post-refractive surgery patient
[caption id="attachment_7411" align="alignnone" width="750"] Valentijn SC Webers[/caption] The Barrett True K intraocular lens (IOL) calculation formula provided better results than the ORA intraoperative aberrometer (Alcon) in a patient who had previously undergone radial keratotomy (RK), said Valentijn SC Webers MD, in a case study he presented at Cornea Day at the 21st ESCRS Winter Meeting in Maastricht, The Netherlands. The patient, a 50-year-old man, had a very unusual eye. Apart from undergoing previous RK with five cuts for high myopia, he had an axial length of 30mm and a very flat K-reading of 30D. He presented with a progressive cataract that had reduced his visual acuity to a decimal value of 0.4, noted Dr Webers, of University Eye Clinic Maastricht, The Netherlands. Dr Webers and his associates opted to perform femtosecond laser-assisted cataract surgery and also perform intraoperative IOL calculation with the ORA device. Preoperative IOL calculations performed with the Barrett True K IOL calculation formula suggested using a 12.5D IOL, however intraoperative measurements suggested using a 14.5D IOL. In the end the Maastricht team compromised and implanted a 13.0D monofocal IOL, which, according to the ORA should have yielded a postoperative spherical equivalent refraction of 0.00D, but according to the Barrett True K formula would result in a postoperative refraction of -1.5D. They found that at one day postoperative the spherical equivalent was 0.25D, very close to that predicted by the ORA. However, by six weeks the spherical equivalent was 1.5D, exactly as predicted by the Barrett True K formula.
Latest Articles
From Lab to Life: Corneal Repair Goes Cellular

Long-awaited cellular therapies for corneal endothelial disease enter the clinic.

Read more...

Balancing Innovation and Safety

Ensuring access to advanced cell therapies amid regulatory overhaul.

Read more...

With Eyes on Its Future, ESCRS Celebrates Its Past

Winter Meeting offers opportunities to experiment with new concepts and formats.

Read more...

Best of ESCRS Winter Meeting 2024

Read more...

Following the New Generation

EDOF IOLs an option for eyes with mild comorbidities, showing potential in mini-monovision strategies.

Read more...

Refocus on Multifocals

Trifocal IOLs continue to improve as consensus grows regarding indications and contraindications.

Read more...

Common Myths in Presbyopia Correction

Patient education key to satisfaction with refractive IOLs.

Read more...

Reversible Multifocality

Two-lens combination offers low-risk spectacle independence for cataract patients and presbyopes.

Read more...

Managing a Cataract Surgery Refractive Miss

Weighing the pros and cons of options for intraocular intervention.

Read more...

Unleashing OCT’s Full Potential

Performance of newest tool for corneal evaluation meets or beats older standard technologies.

Read more...

;